Clinical Study Reveals Snorenz Effective
“This study has clearly shown that a commercially available product (Snorenz(R) Spray) can also be beneficial for snoring.”
BOCA RATON, Fla.--(BUSINESS WIRE)--June 7, 2004--Med Gen Inc. (OTCBB:MDGN), manufacturers of the national brands Snorenz(R), snore relief throat spray and Good Night's Sleep(R), sleep aid throat spray, announced today that it has received the results of a two year study advocating the advantages of Snorenz(R) as a relief to the millions of snoring sufferers world-wide.
The clinical study, headed by Drs. Samuel A. Mickelson MD, FACS, ABSM and Andrew R. Golde, MD, was conducted at The Atlanta Snoring & Sleep Disorders Institute and the Advanced Ear Nose & Throat Associates PC. The study was also approved by the Institutional review board at Northside Hospital, Atlanta, Georgia.
The clinical (double blind) study concludes: "Data analysis showed (that Snorenz(R) produced) a statistically significant improvement and beneficial treatment effect on three outcomes measures including the snore index, snore 25 score and type 2 snoring. In a survey of bed partners, Snorenz(R) was 57.5% more effective than a placebo in reducing snoring. As compared to placebo, the use of Snorenz(R) reduced the number of snores per hour, improved quality of life as measured by the Snore 25 questionnaire, and altered the character of snoring." The clinical study further asserts, "This study has clearly shown that a commercially available product (Snorenz(R) Spray) can also be beneficial for snoring."
Snorenz(R), by Med Gen Inc. (OTCBB:MDGN) was first to introduce a liquid throat spray delivery system in 1997 using all natural ingredients. The formula was novel enough to have been awarded a US patent in 1999. Since then, many "copycat" products have surfaced but none have committed themselves to the testing and scrutiny that Snorenz(R) has and none have the Patented long lasting formula that makes the solution work.
Snorenz(R) can be found at leading stores nationally, including Wal-Mart, Walgreen's, Eckerd Drug, Albertson's, CVS, Osco and Sav-On Drugs. If you cannot locate Snorenz(R) call Med Gen Inc. 561-750-1100.
This Press Release contains or incorporates by reference "forward-looking" statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward-looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward-looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward-looking statements.
AI
